PT936217E - Compostos de 1-fenilpirazole e sua utilizacao em medicina - Google Patents
Compostos de 1-fenilpirazole e sua utilizacao em medicinaInfo
- Publication number
- PT936217E PT936217E PT97909603T PT97909603T PT936217E PT 936217 E PT936217 E PT 936217E PT 97909603 T PT97909603 T PT 97909603T PT 97909603 T PT97909603 T PT 97909603T PT 936217 E PT936217 E PT 936217E
- Authority
- PT
- Portugal
- Prior art keywords
- compounds
- phenylpirazole
- medicine
- hyperuricacidemia
- isobutoxyphenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Epoxy Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP28447996 | 1996-10-25 | ||
JP5578697 | 1997-03-11 | ||
JP26130597 | 1997-09-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT936217E true PT936217E (pt) | 2002-05-31 |
Family
ID=27295710
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT97909603T PT936217E (pt) | 1996-10-25 | 1997-10-22 | Compostos de 1-fenilpirazole e sua utilizacao em medicina |
Country Status (17)
Country | Link |
---|---|
US (1) | US6015829A (pt) |
EP (1) | EP0936217B1 (pt) |
JP (1) | JP3220987B2 (pt) |
KR (1) | KR100345942B1 (pt) |
CN (1) | CN1105708C (pt) |
AT (1) | ATE208379T1 (pt) |
AU (1) | AU731055B2 (pt) |
CA (1) | CA2269721C (pt) |
DE (1) | DE69708142T2 (pt) |
DK (1) | DK0936217T3 (pt) |
ES (1) | ES2167720T3 (pt) |
HK (1) | HK1021982A1 (pt) |
ID (1) | ID21775A (pt) |
IL (1) | IL129409A (pt) |
PL (1) | PL332946A1 (pt) |
PT (1) | PT936217E (pt) |
WO (1) | WO1998018765A1 (pt) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6569885B1 (en) * | 1999-12-23 | 2003-05-27 | Icos Corporation | Cyclic AMP-specific phosphodiesterase inhibitors |
AU2001277731A1 (en) * | 2000-08-09 | 2002-02-18 | Welfide Corporation | Fused bicyclic amide compounds and medicinal use thereof |
JP4532408B2 (ja) * | 2003-03-13 | 2010-08-25 | 田辺三菱製薬株式会社 | 腫瘍形成抑制剤 |
PL1757610T3 (pl) | 2004-06-14 | 2011-10-31 | Nippon Chemiphar Co | Skondensowana pochodna pirymidyny oraz inhibitor oksydazy ksantynowej |
JP4894517B2 (ja) * | 2004-08-27 | 2012-03-14 | アステラス製薬株式会社 | 2−フェニルピリジン誘導体 |
JPWO2006022375A1 (ja) * | 2004-08-27 | 2008-05-08 | アステラス製薬株式会社 | 2−フェニルチオフェン誘導体 |
EP1883405A4 (en) | 2005-05-09 | 2010-01-27 | Takeda Pharmaceuticals North A | METHODS OF TREATING NEPHROLITHIASIS |
EP1940397A4 (en) * | 2005-08-03 | 2010-01-20 | Takeda Pharmaceuticals North A | METHOD FOR TREATING HYPERTONIA |
JP5222561B2 (ja) * | 2005-10-07 | 2013-06-26 | キッセイ薬品工業株式会社 | 含窒素芳香族複素環化合物およびそれを含有する医薬組成物 |
CN101282934A (zh) | 2005-10-07 | 2008-10-08 | 安斯泰来制药株式会社 | 三芳基羧酸衍生物 |
CN101389352B (zh) | 2006-02-24 | 2012-09-19 | 安斯泰来制药株式会社 | 治疗或预防消化道溃疡的药物 |
WO2008010315A1 (fr) * | 2006-07-19 | 2008-01-24 | Nippon Medical School Foundation | Agent thérapeutique destiné à la sclérose latérale amyotrophique |
US20090124623A1 (en) * | 2006-11-13 | 2009-05-14 | Christopher Lademacher | Methods for preserving and/or increasing renal function using xanthine oxidoreductase inhibitors |
KR20090103879A (ko) * | 2006-11-13 | 2009-10-01 | 다케다 파마슈티칼스 노쓰 어메리카, 인코포레이티드 | 크산틴 옥시도리덕타아제 억제제를 사용하여 신장 기능을 보존하는 방법 |
RU2009131454A (ru) * | 2007-01-19 | 2011-02-27 | Такеда Фармасьютикалз Норт Америка, Инк. (Us) | Способы предупреждения или уменьшения числа обострений подагры с применением ингибиторов ксантиноксидоредуктазы и противовоспалительных средств |
JP5330990B2 (ja) * | 2007-04-11 | 2013-10-30 | キッセイ薬品工業株式会社 | 含窒素複素環化合物およびそれを含有する医薬組成物 |
BRPI0810523A2 (pt) * | 2007-04-11 | 2014-10-21 | Kissei Pharmaceutical | Derivado heterocíclico de 5 membros e uso do mesmo para propósitos médicos. |
CA2682391C (en) | 2007-04-11 | 2014-07-08 | Kissei Pharmaceutical Co., Ltd. | (aza)indole derivative and use thereof for medical purposes |
CN101386605B (zh) * | 2008-10-23 | 2010-09-08 | 中国科学院上海药物研究所 | 非布司他新型晶体及其制备方法 |
US20100311756A1 (en) * | 2009-01-22 | 2010-12-09 | Takeda Pharmaceuticals North America, Inc. | Methods for delaying the progression of at least one of cardiac hypertrophy, cardiac remodeling or left ventricular function or the onset of heart failure in subjects in need of treatment thereof |
RU2510393C9 (ru) | 2009-02-27 | 2014-08-27 | Тейдзин Фарма Лимитед | Способ получения фенилзамещенного гетероциклического производного посредством сочетания с использованием переходного металла в качестве катализатора |
CN101580495A (zh) * | 2009-05-25 | 2009-11-18 | 沈阳药科大学 | 5-取代苯基-3-异噁唑甲酸及其酯类化合物、组合物及其制备方法 |
TWI423962B (zh) | 2009-10-07 | 2014-01-21 | Lg Life Sciences Ltd | 有效作為黃嘌呤氧化酶抑制劑之新穎化合物、其製備方法及含該化合物之醫藥組成物 |
WO2011103439A1 (en) * | 2010-02-19 | 2011-08-25 | Takeda Pharmaceuticals North America, Inc. | Methods for stabilizing joint damage in subjects using xanthine oxidoreductase inhibitors |
MX353203B (es) | 2010-08-27 | 2018-01-05 | Teijin Pharma Ltd | Metodo para producir un derivado heterociclico fenilo sustituido por medio del metodo de acoplamiento utilizando un compuesto paladio. |
KR101797936B1 (ko) | 2010-09-10 | 2017-11-15 | 다케다 파마슈티칼스 유에스에이, 인코포레이티드 | 테오필린과 페북소스타트의 병용 치료 방법 |
CN102766099B (zh) * | 2012-08-07 | 2015-09-23 | 沈阳药科大学 | 具有黄嘌呤氧化酶抑制活性的化合物及其盐、制备方法和用途 |
CN103848798B (zh) | 2012-11-30 | 2016-01-06 | 镇江新元素医药科技有限公司 | 2-芳基硒唑化合物及其药物组合物 |
MY176149A (en) | 2013-03-29 | 2020-07-24 | Teijin Pharma Ltd | Pyrazole derivative |
CN105294584A (zh) * | 2015-11-30 | 2016-02-03 | 中国医科大学 | 1-取代苯基-1h-1,2,3-三唑类化合物、制备方法及其用途 |
CN106279024B (zh) * | 2016-07-19 | 2018-09-14 | 华南理工大学 | 一种黄嘌呤氧化还原酶抑制剂及其制备方法与应用 |
CN106632245B (zh) * | 2016-09-30 | 2019-11-15 | 华南理工大学 | 氮取代基苯基吡唑类黄嘌呤氧化还原酶抑制剂及制备与应用 |
CN108218777A (zh) * | 2017-12-13 | 2018-06-29 | 华南理工大学 | 一种硫取代苯基吡唑类xor抑制剂及制备与应用 |
CN110078668B (zh) * | 2019-05-16 | 2023-03-24 | 华南理工大学 | 一种苯基咪唑类xor抑制剂及制备与应用 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5527916B2 (pt) * | 1973-02-05 | 1980-07-24 | ||
JPS5527916A (en) * | 1978-08-17 | 1980-02-28 | Arekusandorouitsuchi B Nikorai | Detecting icing on objects in gas flow and device therefor |
US4346094A (en) * | 1980-09-22 | 1982-08-24 | Eli Lilly And Company | 3-Aryl-5-isothiazolecarboxylic acids and related compounds used to lower uric acid levels |
DE3129429A1 (de) * | 1981-07-25 | 1983-02-10 | Basf Ag, 6700 Ludwigshafen | 5-amino-1-phenyl-pyrazol-4-carbonsaeurederivate, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung unerwuenschten pflanzenwuchses |
US4495195A (en) * | 1982-11-01 | 1985-01-22 | Eli Lilly And Company | Xanthine oxidase inhibiting 3(5)-phenyl-substituted-5(3)-pyrazole-carboxylic acid derivatives, compositions, and methods of use |
ZA847986B (en) * | 1983-10-15 | 1985-06-26 | Bayer Ag | Substituted 5-acylamino-1-phenylpyrazoles |
DE3420985A1 (de) * | 1983-10-15 | 1985-04-25 | Bayer Ag, 5090 Leverkusen | Substituierte 5-acylamino-1-phenylpyrazole |
IL73419A (en) * | 1983-11-07 | 1988-02-29 | Lilly Co Eli | 1h-pyrazole-4-(thio)carboxamide derivatives,their preparation and herbicidal compositions containing them |
IL73418A (en) * | 1983-11-07 | 1988-02-29 | Lilly Co Eli | 5-cyano-1h-pyrazole-4-(thio)carboxamide derivatives,their preparation and herbicidal compositions containing them |
DE3423582A1 (de) * | 1984-06-27 | 1986-01-09 | Bayer Ag, 5090 Leverkusen | Substituierte 5-acylamino-1-phenylpyrazole |
US4666504A (en) * | 1984-09-25 | 1987-05-19 | Eli Lilly And Company | Pollen formation inhibiting 1-phenyl-4-carboxy-5-pyrazolecarboxamides |
US5064851A (en) * | 1990-07-24 | 1991-11-12 | Pfizer Inc. | 3-(1-substituted-pyrazoyl)-2-oxindole derivatives, compositions and use |
ES2092580T3 (es) * | 1990-11-30 | 1996-12-01 | Teijin Ltd | Derivado de 2-ariltiazol y composicion farmaceutica que contiene el mismo. |
IL104311A (en) * | 1992-02-05 | 1997-07-13 | Fujisawa Pharmaceutical Co | Pyrazole derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same |
US5436258A (en) * | 1992-09-09 | 1995-07-25 | Eli Lilly And Company | Prevention of bone resorption |
JP3113110B2 (ja) * | 1993-01-19 | 2000-11-27 | 帝人株式会社 | イソキサゾールおよびイソチアゾール誘導体 |
-
1996
- 1996-10-25 ID IDW990226A patent/ID21775A/id unknown
-
1997
- 1997-10-22 CA CA002269721A patent/CA2269721C/en not_active Expired - Fee Related
- 1997-10-22 EP EP97909603A patent/EP0936217B1/en not_active Expired - Lifetime
- 1997-10-22 DK DK97909603T patent/DK0936217T3/da active
- 1997-10-22 PT PT97909603T patent/PT936217E/pt unknown
- 1997-10-22 KR KR1019997003538A patent/KR100345942B1/ko not_active IP Right Cessation
- 1997-10-22 IL IL12940997A patent/IL129409A/en not_active IP Right Cessation
- 1997-10-22 AT AT97909603T patent/ATE208379T1/de not_active IP Right Cessation
- 1997-10-22 JP JP51740198A patent/JP3220987B2/ja not_active Expired - Fee Related
- 1997-10-22 DE DE69708142T patent/DE69708142T2/de not_active Expired - Lifetime
- 1997-10-22 WO PCT/JP1997/003840 patent/WO1998018765A1/ja active IP Right Grant
- 1997-10-22 CN CN97180548A patent/CN1105708C/zh not_active Expired - Fee Related
- 1997-10-22 AU AU47230/97A patent/AU731055B2/en not_active Ceased
- 1997-10-22 US US09/155,155 patent/US6015829A/en not_active Expired - Lifetime
- 1997-10-22 PL PL97332946A patent/PL332946A1/xx unknown
- 1997-10-22 ES ES97909603T patent/ES2167720T3/es not_active Expired - Lifetime
-
2000
- 2000-02-18 HK HK00100989A patent/HK1021982A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
ID21775A (id) | 1999-07-22 |
IL129409A (en) | 2002-02-10 |
PL332946A1 (en) | 1999-10-25 |
KR20000052738A (ko) | 2000-08-25 |
AU4723097A (en) | 1998-05-22 |
CA2269721C (en) | 2003-04-29 |
IL129409A0 (en) | 2000-02-17 |
ATE208379T1 (de) | 2001-11-15 |
ES2167720T3 (es) | 2002-05-16 |
DE69708142T2 (de) | 2002-07-11 |
KR100345942B1 (ko) | 2002-07-27 |
JP3220987B2 (ja) | 2001-10-22 |
WO1998018765A1 (fr) | 1998-05-07 |
AU731055B2 (en) | 2001-03-22 |
CN1240432A (zh) | 2000-01-05 |
HK1021982A1 (en) | 2000-07-21 |
EP0936217A4 (en) | 2000-01-05 |
EP0936217A1 (en) | 1999-08-18 |
DK0936217T3 (da) | 2002-03-04 |
CA2269721A1 (en) | 1998-05-07 |
US6015829A (en) | 2000-01-18 |
CN1105708C (zh) | 2003-04-16 |
EP0936217B1 (en) | 2001-11-07 |
DE69708142D1 (de) | 2001-12-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT936217E (pt) | Compostos de 1-fenilpirazole e sua utilizacao em medicina | |
DK233586D0 (da) | 5-substituerede 1,3-thiazolidon-2,4-dion-forbindelser og farmaceutiske praeparater indeholdende disse | |
BG101112A (en) | The use of heterocyclic compounds | |
LU91145I2 (fr) | FIROCOXIB facultativement sous forme d'un sel pharmaceutiquement acceptable (PREVICOX). | |
NO995006L (no) | Nye forbindelser | |
IL129998A0 (en) | Novel substituted pyrazole derivatives for the treatment of cardiocirculatory diseases | |
DK0468012T3 (da) | 17beta-substituerede 4-aza-5alfa-androstan-3-on-derivater og fremgangsmåde til fremstilling deraf | |
DE60025848D1 (en) | Pyrimidin-derivate als selective inhibitoren von cox-2 | |
GR3032220T3 (en) | Use of 2-(N-(2-aminoethyl)amino)acetic acid derivatives for the treatment of diseases which are mediated by non-enzymatical glycosylation | |
CA2371012A1 (en) | 4-(1h-pyrrol-1-yl) imidazoles | |
DE50011034D1 (de) | N-substituierte 4-aminopteridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
FI953899A (fi) | Substituoituja atsolonijohdannaisia Helicobacterin aiheuttamien sairauksien hoitamiseksi | |
ATE79257T1 (de) | Verwendung von tetrahydrobenz(c,d>indol-6carboxamiden zur herstellung von arzneimitteln zur behandlung von angstzustaenden. | |
DK0682947T3 (da) | Medikament til terapeutisk og profylaktisk behandling af sygdomme forårsaget af glatmuskelcelle-hyperplasi | |
CA2219359A1 (en) | Hydantoin derivatives as intermediates for pharmaceutical active compounds | |
DK383388A (da) | 3-demethyl-4-fluor-mevalonsyrederivater, deres fremstilling, farmaceutiske praeparater deraf, deres anvendelse og mellemprodukter til deres fremstilling | |
DE69411906D1 (de) | Herbizide substituierte 1-phenyl-oder 1-pyridinyl-benzotriazole | |
DK0758312T3 (da) | Substituerede fusionerede og broforbundne bicykliske forbindelser som terapeutiske midler | |
PT855398E (pt) | Derivados sasquiterpeno tendo actividade antiviral | |
NO170014C (no) | Analogifremgangsmaate for fremstilling av den terapeutisk aktive forbindelse (3s(z))-2-(((1-(2-amino-4-tiazolyl)-2-((2,2-dimetyl-4-okso-1-(sulfooksy)-3-azetidinyl)amino)-2-oksoetyliden)amino)oksy)-eddiksyre | |
NO913644D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater. | |
AP9400608A0 (en) | "New nicotinic acid derivative". | |
DE59606437D1 (de) | 5-pyrazolylbenzosäure-derivate als herbizide | |
ATE80629T1 (de) | Beta-lactam-antibiotika, verfahren zu ihrer herstellung und ihre verwendung als und in arzneimitteln. | |
ITMI920525A1 (it) | Derivato dell'acido l-tiazolidin-4-carbossilico, sua preparazione e suo impiego terapeutico |